Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype, an International Phase III, Double-blind, Placebo-controlled, Randomized Trial

NCT06269900 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT06269900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06269900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype, an International Phase III, Double-blind, Placebo-controlled, Randomized Trial
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
March 26, 2024
Completion date
March 15, 2027
Enrollment
450 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

hospital acquired pneumonia